GenIBET Biopharmaceuticals Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • M&A
  • Investors
  • 1

GenIBET Biopharmaceuticals General Information


Provider of contract manufacturing services which offers comprehensive services that encompasses cell line development, process and analytical development. The company's contract manufacturing services offers specialized microbial, cell culture and viral-process development and current good manufacturing practice (cGMP) services, enabling research groups, biotech and pharma companies to get the opportunity to go from bench to clinic in one facility.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Rua Melvin Jones, 1
  • Loja C e D
  • Oeiras, 2780-133
  • Portugal
+351 21 000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GenIBET Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 28-Feb-2019 Completed Generating Revenue
1. PE Growth/Expansion Completed Generating Revenue
To view GenIBET Biopharmaceuticals’s complete valuation and funding history, request access »

GenIBET Biopharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Raquel Fortunato Ph.D Chief Executive Officer
To view GenIBET Biopharmaceuticals’s complete executive team members history, request access »

GenIBET Biopharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Portugal Ventures Venture Capital Minority 000 0000 000000 0
To view GenIBET Biopharmaceuticals’s complete investors history, request access »